When does this change take effect?

This change is effective Aug 20, 2025.

Back to dashboard

CommercialAdministrativeMedium impact

08.01.12e, Repository Corticotropin Injection (Acthar® Gel, Purified Cortrophin® Gel)

Q: Who is affected by this change?

This affects Independence Blue Cross Endocrinology, Rheumatology, Neurology, Nephrology providers on Commercial plans.

Independence Blue Cross·Endocrinology, Rheumatology, Neurology +1 more·Pharmacy

Effective date

Aug 20, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

This is a reissue of an existing policy for Repository Corticotropin Injection (Acthar® Gel, Purified Cortrophin® Gel) under commercial plans. The policy has been updated and reposted with an effective date of August 20, 2025.

Action Required

Action needed

By August 20, 2025: Billing team should review the updated policy for Repository Corticotropin Injection (Acthar® Gel, Purified Cortrophin® Gel) at the provided URL to identify any changes in coverage criteria, prior authorization requirements, or billing procedures. Update internal protocols and staff training accordingly for commercial plan claims.

Related policy hubs

Independence Blue Cross policies Endocrinology Rheumatology Neurology Nephrology